February 28, 2014 — Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment, clinical research from New Zealand shows.

Although many skincare products have been tested in clinical trials over the years, until now none have been able to completely prevent severe skin reactions, said senior lecturer Patries Herst of University of Otago Wellington's department of radiation therapy.

Herst and her team of radiation therapists, oncology nurses and medical physicists have completed five randomized controlled clinical trials in public hospitals in Dunedin, Wellington, Palmerston North and Auckland Radiation Oncology over the past five years, all focusing on side effects caused by radiation therapy.

Their most recent trial was in collaboration with Dunedin Hospital, and demonstrated it is possible to prevent skin reactions from developing in breast cancer patients undergoing radiation therapy.

Skin reactions are common in these patients, ranging from mild redness to ulceration with symptoms of pain, burning and itchiness, Herst said.

The dressings work by adhering closely to the small folds in the skin without the use of adhesives, so do not stick to open wounds. By protecting the radiation-damaged skin from friction against items of clothing or other parts of the body, they allow the stem cells of the skin to heal from the radiation damage in an undisturbed environment. The dressings are also free of chemicals that could react with the skin.

Herst is currently setting up a trial that will test the dressings in head and neck cancer patients.

The results have been published online in Radiotherapy and Oncology.

For more information: www.journals.elsevier.com/radiotherapy-and-oncology


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Artificial Intelligence

June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and ...

Time June 11, 2024
arrow
Subscribe Now